nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Trauma—Bleomycin—testicular cancer	0.037	0.037	CcSEcCtD
Methocarbamol—Nystagmus—Vinblastine—testicular cancer	0.0292	0.0292	CcSEcCtD
Methocarbamol—Taste metallic—Methotrexate—testicular cancer	0.0224	0.0224	CcSEcCtD
Methocarbamol—Injury—Bleomycin—testicular cancer	0.0139	0.0139	CcSEcCtD
Methocarbamol—Pain—Carboplatin—testicular cancer	0.0135	0.0135	CcSEcCtD
Methocarbamol—Thrombophlebitis—Ifosfamide—testicular cancer	0.0126	0.0126	CcSEcCtD
Methocarbamol—Body temperature increased—Carboplatin—testicular cancer	0.0125	0.0125	CcSEcCtD
Methocarbamol—Jaundice—Chlorambucil—testicular cancer	0.0124	0.0124	CcSEcCtD
Methocarbamol—Amnesia—Ifosfamide—testicular cancer	0.0116	0.0116	CcSEcCtD
Methocarbamol—Nasal congestion—Cisplatin—testicular cancer	0.0103	0.0103	CcSEcCtD
Methocarbamol—Amnesia—Cisplatin—testicular cancer	0.01	0.01	CcSEcCtD
Methocarbamol—Nystagmus—Epirubicin—testicular cancer	0.00932	0.00932	CcSEcCtD
Methocarbamol—Angioedema—Chlorambucil—testicular cancer	0.00908	0.00908	CcSEcCtD
Methocarbamol—Leukopenia—Chlorambucil—testicular cancer	0.0089	0.0089	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—testicular cancer	0.00863	0.00863	CcSEcCtD
Methocarbamol—Convulsion—Chlorambucil—testicular cancer	0.00861	0.00861	CcSEcCtD
Methocarbamol—Flushing—Bleomycin—testicular cancer	0.0082	0.0082	CcSEcCtD
Methocarbamol—Vertigo—Vinblastine—testicular cancer	0.00818	0.00818	CcSEcCtD
Methocarbamol—Confusional state—Chlorambucil—testicular cancer	0.00818	0.00818	CcSEcCtD
Methocarbamol—Conjunctivitis—Ifosfamide—testicular cancer	0.00818	0.00818	CcSEcCtD
Methocarbamol—Leukopenia—Vinblastine—testicular cancer	0.00815	0.00815	CcSEcCtD
Methocarbamol—Convulsion—Vinblastine—testicular cancer	0.00789	0.00789	CcSEcCtD
Methocarbamol—Bradycardia—Ifosfamide—testicular cancer	0.00769	0.00769	CcSEcCtD
Methocarbamol—Flushing—Dactinomycin—testicular cancer	0.00765	0.00765	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—testicular cancer	0.00758	0.00758	CcSEcCtD
Methocarbamol—Dyspepsia—Chlorambucil—testicular cancer	0.00714	0.00714	CcSEcCtD
Methocarbamol—Conjunctivitis—Cisplatin—testicular cancer	0.00705	0.00705	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—testicular cancer	0.00701	0.00701	CcSEcCtD
Methocarbamol—Flushing—Ifosfamide—testicular cancer	0.00701	0.00701	CcSEcCtD
Methocarbamol—Pain—Chlorambucil—testicular cancer	0.00694	0.00694	CcSEcCtD
Methocarbamol—Leukopenia—Bleomycin—testicular cancer	0.00689	0.00689	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—testicular cancer	0.00678	0.00678	CcSEcCtD
Methocarbamol—Feeling abnormal—Chlorambucil—testicular cancer	0.00669	0.00669	CcSEcCtD
Methocarbamol—Bradycardia—Cisplatin—testicular cancer	0.00663	0.00663	CcSEcCtD
Methocarbamol—Jaundice—Etoposide—testicular cancer	0.00648	0.00648	CcSEcCtD
Methocarbamol—Urticaria—Chlorambucil—testicular cancer	0.00645	0.00645	CcSEcCtD
Methocarbamol—Leukopenia—Dactinomycin—testicular cancer	0.00642	0.00642	CcSEcCtD
Methocarbamol—Body temperature increased—Chlorambucil—testicular cancer	0.00641	0.00641	CcSEcCtD
Methocarbamol—Pain—Vinblastine—testicular cancer	0.00636	0.00636	CcSEcCtD
Methocarbamol—Confusional state—Bleomycin—testicular cancer	0.00633	0.00633	CcSEcCtD
Methocarbamol—Anaphylactic shock—Bleomycin—testicular cancer	0.00628	0.00628	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—testicular cancer	0.00627	0.00627	CcSEcCtD
Methocarbamol—Vision blurred—Ifosfamide—testicular cancer	0.0062	0.0062	CcSEcCtD
Methocarbamol—Feeling abnormal—Vinblastine—testicular cancer	0.00613	0.00613	CcSEcCtD
Methocarbamol—Flushing—Cisplatin—testicular cancer	0.00604	0.00604	CcSEcCtD
Methocarbamol—Angioedema—Ifosfamide—testicular cancer	0.00601	0.00601	CcSEcCtD
Methocarbamol—Hypersensitivity—Chlorambucil—testicular cancer	0.00598	0.00598	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methotrexate—testicular cancer	0.00597	0.00597	CcSEcCtD
Methocarbamol—Vertigo—Ifosfamide—testicular cancer	0.00591	0.00591	CcSEcCtD
Methocarbamol—Leukopenia—Ifosfamide—testicular cancer	0.00589	0.00589	CcSEcCtD
Methocarbamol—Hypotension—Bleomycin—testicular cancer	0.00587	0.00587	CcSEcCtD
Methocarbamol—Pruritus—Chlorambucil—testicular cancer	0.00574	0.00574	CcSEcCtD
Methocarbamol—Convulsion—Ifosfamide—testicular cancer	0.0057	0.0057	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—testicular cancer	0.00558	0.00558	CcSEcCtD
Methocarbamol—Flushing—Etoposide—testicular cancer	0.00554	0.00554	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinblastine—testicular cancer	0.00548	0.00548	CcSEcCtD
Methocarbamol—Confusional state—Ifosfamide—testicular cancer	0.00541	0.00541	CcSEcCtD
Methocarbamol—Pain—Bleomycin—testicular cancer	0.00537	0.00537	CcSEcCtD
Methocarbamol—Anaphylactic shock—Ifosfamide—testicular cancer	0.00537	0.00537	CcSEcCtD
Methocarbamol—Vision blurred—Cisplatin—testicular cancer	0.00534	0.00534	CcSEcCtD
Methocarbamol—Feeling abnormal—Bleomycin—testicular cancer	0.00517	0.00517	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—testicular cancer	0.00517	0.00517	CcSEcCtD
Methocarbamol—Vomiting—Chlorambucil—testicular cancer	0.00516	0.00516	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—testicular cancer	0.00509	0.00509	CcSEcCtD
Methocarbamol—Leukopenia—Cisplatin—testicular cancer	0.00507	0.00507	CcSEcCtD
Methocarbamol—Hypotension—Ifosfamide—testicular cancer	0.00501	0.00501	CcSEcCtD
Methocarbamol—Pain—Dactinomycin—testicular cancer	0.00501	0.00501	CcSEcCtD
Methocarbamol—Urticaria—Bleomycin—testicular cancer	0.00499	0.00499	CcSEcCtD
Methocarbamol—Body temperature increased—Bleomycin—testicular cancer	0.00496	0.00496	CcSEcCtD
Methocarbamol—Dizziness—Vinblastine—testicular cancer	0.00492	0.00492	CcSEcCtD
Methocarbamol—Convulsion—Cisplatin—testicular cancer	0.00491	0.00491	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—testicular cancer	0.00483	0.00483	CcSEcCtD
Methocarbamol—Feeling abnormal—Dactinomycin—testicular cancer	0.00483	0.00483	CcSEcCtD
Methocarbamol—Nausea—Chlorambucil—testicular cancer	0.00482	0.00482	CcSEcCtD
Methocarbamol—Somnolence—Ifosfamide—testicular cancer	0.00477	0.00477	CcSEcCtD
Methocarbamol—Vomiting—Vinblastine—testicular cancer	0.00473	0.00473	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—testicular cancer	0.00467	0.00467	CcSEcCtD
Methocarbamol—Headache—Vinblastine—testicular cancer	0.00466	0.00466	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—testicular cancer	0.00465	0.00465	CcSEcCtD
Methocarbamol—Body temperature increased—Dactinomycin—testicular cancer	0.00463	0.00463	CcSEcCtD
Methocarbamol—Anaphylactic shock—Cisplatin—testicular cancer	0.00463	0.00463	CcSEcCtD
Methocarbamol—Hypersensitivity—Bleomycin—testicular cancer	0.00463	0.00463	CcSEcCtD
Methocarbamol—Pain—Ifosfamide—testicular cancer	0.00459	0.00459	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—testicular cancer	0.00456	0.00456	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—testicular cancer	0.0045	0.0045	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—testicular cancer	0.00447	0.00447	CcSEcCtD
Methocarbamol—Pruritus—Bleomycin—testicular cancer	0.00444	0.00444	CcSEcCtD
Methocarbamol—Feeling abnormal—Ifosfamide—testicular cancer	0.00442	0.00442	CcSEcCtD
Methocarbamol—Nausea—Vinblastine—testicular cancer	0.00442	0.00442	CcSEcCtD
Methocarbamol—Hypotension—Cisplatin—testicular cancer	0.00432	0.00432	CcSEcCtD
Methocarbamol—Hypersensitivity—Dactinomycin—testicular cancer	0.00431	0.00431	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—testicular cancer	0.00427	0.00427	CcSEcCtD
Methocarbamol—Urticaria—Ifosfamide—testicular cancer	0.00426	0.00426	CcSEcCtD
Methocarbamol—Body temperature increased—Ifosfamide—testicular cancer	0.00424	0.00424	CcSEcCtD
Methocarbamol—Anaphylactic shock—Etoposide—testicular cancer	0.00424	0.00424	CcSEcCtD
Methocarbamol—Vomiting—Bleomycin—testicular cancer	0.00399	0.00399	CcSEcCtD
Methocarbamol—Drowsiness—Methotrexate—testicular cancer	0.00398	0.00398	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—testicular cancer	0.00396	0.00396	CcSEcCtD
Methocarbamol—Rash—Bleomycin—testicular cancer	0.00396	0.00396	CcSEcCtD
Methocarbamol—Pain—Cisplatin—testicular cancer	0.00396	0.00396	CcSEcCtD
Methocarbamol—Dermatitis—Bleomycin—testicular cancer	0.00396	0.00396	CcSEcCtD
Methocarbamol—Hypersensitivity—Ifosfamide—testicular cancer	0.00395	0.00395	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—testicular cancer	0.00387	0.00387	CcSEcCtD
Methocarbamol—Feeling abnormal—Cisplatin—testicular cancer	0.00381	0.00381	CcSEcCtD
Methocarbamol—Pruritus—Ifosfamide—testicular cancer	0.0038	0.0038	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—testicular cancer	0.00377	0.00377	CcSEcCtD
Methocarbamol—Nausea—Bleomycin—testicular cancer	0.00373	0.00373	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—testicular cancer	0.00373	0.00373	CcSEcCtD
Methocarbamol—Vomiting—Dactinomycin—testicular cancer	0.00372	0.00372	CcSEcCtD
Methocarbamol—Rash—Dactinomycin—testicular cancer	0.00369	0.00369	CcSEcCtD
Methocarbamol—Body temperature increased—Cisplatin—testicular cancer	0.00366	0.00366	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—testicular cancer	0.00363	0.00363	CcSEcCtD
Methocarbamol—Pain—Etoposide—testicular cancer	0.00362	0.00362	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—testicular cancer	0.00362	0.00362	CcSEcCtD
Methocarbamol—Dizziness—Ifosfamide—testicular cancer	0.00355	0.00355	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—testicular cancer	0.00349	0.00349	CcSEcCtD
Methocarbamol—Nausea—Dactinomycin—testicular cancer	0.00348	0.00348	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—testicular cancer	0.00345	0.00345	CcSEcCtD
Methocarbamol—Vomiting—Ifosfamide—testicular cancer	0.00341	0.00341	CcSEcCtD
Methocarbamol—Hypersensitivity—Cisplatin—testicular cancer	0.00341	0.00341	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—testicular cancer	0.0034	0.0034	CcSEcCtD
Methocarbamol—Rash—Ifosfamide—testicular cancer	0.00338	0.00338	CcSEcCtD
Methocarbamol—Dermatitis—Ifosfamide—testicular cancer	0.00338	0.00338	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—testicular cancer	0.00337	0.00337	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—testicular cancer	0.00336	0.00336	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—testicular cancer	0.00335	0.00335	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—testicular cancer	0.00335	0.00335	CcSEcCtD
Methocarbamol—Nausea—Ifosfamide—testicular cancer	0.00319	0.00319	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—testicular cancer	0.00315	0.00315	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—testicular cancer	0.00312	0.00312	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—testicular cancer	0.0031	0.0031	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—testicular cancer	0.00305	0.00305	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—testicular cancer	0.003	0.003	CcSEcCtD
Methocarbamol—Vomiting—Cisplatin—testicular cancer	0.00294	0.00294	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—testicular cancer	0.00293	0.00293	CcSEcCtD
Methocarbamol—Rash—Cisplatin—testicular cancer	0.00292	0.00292	CcSEcCtD
Methocarbamol—Dermatitis—Cisplatin—testicular cancer	0.00291	0.00291	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—testicular cancer	0.00287	0.00287	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—testicular cancer	0.00285	0.00285	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—testicular cancer	0.0028	0.0028	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—testicular cancer	0.00279	0.00279	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—testicular cancer	0.00278	0.00278	CcSEcCtD
Methocarbamol—Nausea—Cisplatin—testicular cancer	0.00275	0.00275	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—testicular cancer	0.00274	0.00274	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—testicular cancer	0.0027	0.0027	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—testicular cancer	0.00269	0.00269	CcSEcCtD
Methocarbamol—Rash—Etoposide—testicular cancer	0.00267	0.00267	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—testicular cancer	0.00267	0.00267	CcSEcCtD
Methocarbamol—Headache—Etoposide—testicular cancer	0.00266	0.00266	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—testicular cancer	0.00264	0.00264	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—testicular cancer	0.00261	0.00261	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—testicular cancer	0.00256	0.00256	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methotrexate—testicular cancer	0.00254	0.00254	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—testicular cancer	0.00254	0.00254	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—testicular cancer	0.00252	0.00252	CcSEcCtD
Methocarbamol—Nausea—Etoposide—testicular cancer	0.00252	0.00252	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—testicular cancer	0.00241	0.00241	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—testicular cancer	0.00238	0.00238	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—testicular cancer	0.00237	0.00237	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Methocarbamol—Shock—Epirubicin—testicular cancer	0.00234	0.00234	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—testicular cancer	0.00233	0.00233	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—testicular cancer	0.0023	0.0023	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—testicular cancer	0.00226	0.00226	CcSEcCtD
Methocarbamol—Dyspepsia—Methotrexate—testicular cancer	0.00223	0.00223	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Methocarbamol—Pain—Methotrexate—testicular cancer	0.00217	0.00217	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—testicular cancer	0.00216	0.00216	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—testicular cancer	0.00209	0.00209	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Methocarbamol—Pain—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—testicular cancer	0.00202	0.00202	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—testicular cancer	0.00201	0.00201	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—testicular cancer	0.00195	0.00195	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—testicular cancer	0.0018	0.0018	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—testicular cancer	0.00161	0.00161	CcSEcCtD
Methocarbamol—Rash—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Methocarbamol—Headache—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—testicular cancer	0.00151	0.00151	CcSEcCtD
Methocarbamol—Rash—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Methocarbamol—Headache—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—testicular cancer	0.00141	0.00141	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—testicular cancer	0.00131	0.00131	CcSEcCtD
